| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/02/1992 | EP0501557A1 Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
| 09/02/1992 | EP0501395A1 Method for the production in vitro of replicatable nucleic acids |
| 09/02/1992 | EP0501356A1 Detection of bacteria by nucleic acid amplification |
| 09/02/1992 | EP0501233A1 Hybridomas and monoclonal antibodies that inhibit anti-CD3-stimulated T cell proliferation |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0501140A1 Erecting scaffold moveable along an elevator shaft for erecting shaft equipment |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500799A1 Particle mediated transformation of animal skin tissue cells |
| 09/02/1992 | EP0500791A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 09/02/1992 | EP0500773A1 Non-glycosylated fgf-4 and compositions containing the same |
| 09/02/1992 | EP0500751A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0500699A1 Cross-protective salmonella vaccines |
| 09/02/1992 | EP0500626A1 Promoter, expression vector and polypeptide synthesis |
| 09/02/1992 | EP0493418A4 Method of producing fusion proteins |
| 09/02/1992 | EP0437488A4 Animal model for human disease |
| 09/02/1992 | CN1064018A Processes for preparation of compositions used in treatment of cell generation disorders |
| 09/02/1992 | CA2105303A1 Display phage |
| 09/02/1992 | CA2062097A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 09/02/1992 | CA2061738A1 Antibodies reactive with human cytosolic phospholipase a2 |
| 09/02/1992 | CA2060812A1 Erection scaffolding which is movable in a lift shaft for the mounting of shaft equipment |
| 09/01/1992 | US5144019 Ribozyme cleavage of HIV-I RNA |
| 09/01/1992 | US5143905 Method and means for extending the host range of insecticidal proteins |
| 09/01/1992 | US5143846 Protease deficient bacterial hosts |
| 09/01/1992 | US5143844 Construction of an igg binding protein to facilitate downstream processing using protein engineering |
| 09/01/1992 | US5143836 Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda pl promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof |
| 09/01/1992 | US5143830 Process for the production of a polypeptide |
| 09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed |
| 09/01/1992 | CA1306963C Process for producing l-threonine and l-isoleucine |
| 09/01/1992 | CA1306962C Rhizobium diagnostic sequences |
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins |
| 09/01/1992 | CA1306960C Yeast strains, method of production and use in baking |
| 08/29/1992 | CA2104285A1 Recombinant fiv glycoprotein 160 and p24 gag protein |
| 08/29/1992 | CA2062078A1 Detection of bacteria using a nucleic acid amplification |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/28/1992 | WO1992015682A1 Serine-rich peptide linkers |
| 08/27/1992 | CA2061797A1 Fermentation processes |
| 08/27/1992 | CA2061721A1 Vector containing an inducible selection gene system |
| 08/27/1992 | CA2059824A1 Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation |
| 08/26/1992 | EP0500311A2 Biologically active bacillus thuringiensis isolates and gene encoding a cleopteran-active toxin |
| 08/26/1992 | EP0500290A2 Chromosome-specific staining to detect genetic rearrangements |
| 08/26/1992 | EP0500236A1 Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents |
| 08/26/1992 | EP0500224A2 Exonuclease mediated strand displacement amplification |
| 08/26/1992 | EP0500188A2 Process for the preparation of alpha-acetolactic acid |
| 08/26/1992 | EP0500108A2 Improved activation of recombinant proteins |
| 08/26/1992 | EP0499993A2 Method for producing human nerve growth factor-2 |
| 08/26/1992 | EP0499990A2 Method for producing cysteine-free peptides |
| 08/26/1992 | EP0499834A2 A blood-stage antigen from Plasmodium falciparum, its preparation and use |
| 08/26/1992 | EP0499681A1 PCTD plasmid isolated form chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccins and/or gianostics |
| 08/26/1992 | EP0483219A4 Enhancement of musculature in animals |
| 08/26/1992 | EP0472658A4 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 08/26/1992 | CA2061633A1 Yeast vectors |
| 08/26/1992 | CA2059897A1 Bacillus thuringiensis genes encoding novel coleopteran-active protein toxins |
| 08/25/1992 | US5142047 Uncharged polynucleotide-binding polymers |
| 08/25/1992 | US5142032 Human papillomavirus type 41 dna |
| 08/25/1992 | US5142028 Can be used for elucidation of sugar chain roles in cell functions |
| 08/25/1992 | US5141926 Erythromycin derivatives |
| 08/25/1992 | US5141905 Bone morphogenic proteins induce bone and/or cartilage formation |
| 08/25/1992 | US5141870 Transforming plants with mutant fragment confers herbicide resistance |
| 08/25/1992 | US5141867 Nucleotide sequence encoding a human immunodeficiency virus antigen |
| 08/25/1992 | US5141864 Monoclonal antibody recognizing alpha 2→3 bonds |
| 08/25/1992 | US5141859 Liquefaction of starch, two stage saccharification using enzymes |
| 08/25/1992 | US5141856 Expression of purified ciliary neurotrophic factor |
| 08/25/1992 | US5141851 Isolated farnesyl protein transferase enzyme |
| 08/25/1992 | US5141745 Gene expression |
| 08/25/1992 | US5141131 Method and apparatus for the acceleration of a propellable matter |
| 08/25/1992 | CA1306709C Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 |
| 08/25/1992 | CA1306708C Dicarboxylic acid transport genes |
| 08/25/1992 | CA1306706C Monoclonal antibodies to human gastrointestinal cancer |
| 08/23/1992 | WO1992014825A1 NOVEL PLASMID pBUL1 DERIVED FROM LACTOBACILLUS AND DERIVATIVE THEREOF |
| 08/23/1992 | WO1992014821A2 Nestin expression as an indicator of neuroepithelial tumors |
| 08/23/1992 | CA2104697A1 Nestin expression as an indicator of neuroepithelial tumors |
| 08/23/1992 | CA2079174A1 Plasmid pbul1 derived from a lactobacillus and the derivatives thereof |
| 08/23/1992 | CA2060267A1 Chromosome specific staining to detect genetic rearrangements |
| 08/22/1992 | CA2061575A1 Plasmodium falciparum blood-stage antigen, the preparation and use thereof |
| 08/20/1992 | WO1992014829A1 Viral particles having altered host range |
| 08/20/1992 | WO1992014818A2 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992014136A1 Ellipsometric immunoassay system and method including a thin film detection device |
| 08/20/1992 | WO1992013972A1 Genetically engineered bacteria to identify and produce medically important agents |
| 08/20/1992 | WO1992013965A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/20/1992 | WO1992013963A1 Method for preparation of closed circular dna |
| 08/20/1992 | WO1992013957A1 Stamen-specific promoters from corn |
| 08/20/1992 | WO1992013956A1 Stamen-specific promoters from rice |
| 08/20/1992 | WO1992013955A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/20/1992 | WO1992013953A1 Microbial transformation of recalcitrant pcb compounds |
| 08/20/1992 | WO1992013952A1 Improved inhibitors of thrombin |
| 08/20/1992 | WO1992013951A1 Production of human serum albumin in methylotrophic yeast cells |
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 08/20/1992 | WO1992013949A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/20/1992 | WO1992013948A1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 08/20/1992 | WO1992013945A1 Sg(b)-1,4-galactanase and a dna sequence |
| 08/20/1992 | WO1992013943A1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 08/20/1992 | WO1992013941A1 Novel bacillus thuringiensis isolates |
| 08/20/1992 | WO1992013892A1 Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 08/20/1992 | WO1992013890A1 Nematode vaccine |
| 08/20/1992 | WO1992013889A1 Nematode vaccine |
| 08/20/1992 | WO1992013884A1 Liver-stage-specific peptide sequences of p. falciparum bearing epitopes capable of stimulating the t lymphocytes |